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Abstract
Alcohol dependence is frequently associated with aggressive and suicidal behaviour. Genetic factors
contribute to both behaviours. Candidate genes, related to suicide and aggression, include genes involved
in serotonin, norepinephrine and dopamine pathways. The enzyme catechol-O-methyl transferase
(COMT) degrades dopamine, epinephrine and norepinephrine. The functional polymorphism (COMT
Val108/158Met) aﬀects COMT activity, with the valine (Val) variant associated with higher and the meth-
ionine (Met) variant with lower COMT activity. This polymorphism is associated with aggressive and
suicidal behaviour, but the literature data on this relationship is contradictory and inconsistent. The hy-
pothesis of this study was that Met allele carriers with alcohol dependence will have a higher frequency of
suicide attempts compared to other genotypes. Participants were 312 male and 81 female medication-free
patients with alcohol dependence and 487 male and 122 female unrelated, non-suicidal medication-free
Caucasian healthy subjects. Our results showed signiﬁcant (x2 test with standardized residuals) diﬀer-
ences in the frequencies of COMT variants in all alcoholics, alcoholics with diﬀerent comorbid diagnoses,
and in male but not in female alcoholics, with or without suicide attempts. Male alcoholic suicide at-
tempters, compared to male non-attempters, had the higher frequency of Met/Met genotype or Met allele,
and signiﬁcantly (Kruskal–Wallis ANOVA on ranks and Mann–Whitney test) higher aggression and de-
pression scores. These results conﬁrmed the associations between Met allele and aggressive behaviour or
violent suicide attempts in various psychiatric diagnoses, and suggested that Met allele of the COMT
Val108/158 Met might be used as an independent biomarker of suicidal behaviour across diﬀerent psycho-
pathologies.
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Introduction
Alcohol dependence is frequently associated with
suicidal behaviour (Kessler et al. 1994) and suicide
mortality (Rossow & Amundsen, 1995). Patients with
chronic alcoholism have diﬀerent psychiatric co-
morbidities, and the most frequent psychiatric dis-
orders related to alcohol use disorders are depression,
anxiety, antisocial personality disorder, conduct dis-
order, and attention deﬁcit hyperactivity disorder
(Ducci et al. 2007; Sher, 2006). Patients with alcohol
dependence have a greater suicide risk than the non-
psychiatrically ill subjects, and suicide risk increases
if alcoholism is related to comorbid depression
(Sher, 2006). Alcoholism is associated with various
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dimensions of personality (novelty seeking, harm
avoidance, and reward dependence) and age at onset
(Cloninger, 1987). Personality disorders and impulsive
and aggressive behaviour, together with a tendency to
engage in impulsive violence, are contributory risk
factors for suicidal behaviour and completed suicide
(Brent et al. 1994 ; Diaconu & Turecki, 2007 ; Duberstein
et al. 2000 ; Dumais et al. 2005 ; McGirr & Turecki, 2007;
Sarchiapone et al. 2009), both among psychiatric pa-
tients as well as in the general population. Twin, fam-
ily, and adoption studies suggest an important role of
genetic factors in suicidal behaviour, with genes
playing a role in about 30–50% of cases that involve
suicidal behaviour (Bondy et al. 2006 ; Mann et al. 1999,
2009 ; McGuﬃn et al. 2001 ; Roy et al. 1995 ; Statham
et al. 1998). Candidate genes thought to be related to
suicide are mostly those involved in serotonin and
catecholamine pathways [serotonin transporter (SERT
or 5-HTT), tryptophan hydroxylase (TPH), mono-
amine oxidase (MAOA), serotonin receptors (5-HT1A,
5-HT1B, and 5-HT2A), catechol-O-methyltransferase
(COMT), tyrosine hydroxylase (TH) and DOPA de-
carboxylase] (Mann et al. 2009 ; Slater et al. 2009). The
association between catecholaminergic dysfunction
and suicide behaviour is based on the ﬁndings of a
higher concentration of norepinephrine and decreased
a2-adrenergic binding in the prefrontal cortex of sui-
cide victims (Arango et al. 1993) or lower levels of
3-methoxy-4-hydroxyphenylglycol (a metabolite of
norepinephrine) and homovanillic acid (a metabolite
of dopamine) in the cerebrospinal ﬂuid of subjects
who attempted suicide (Engstrom et al. 1999; Jones
et al. 1990; Roy et al. 1986) than in control subjects.
Preclinical (Gogos et al. 1998; Haller et al. 1998), as well
as clinical (Tardiﬀ, 1981) data have shown that the
elevations in dopamine and norepinephrine levels
increase aggressive behaviour. Approximately 30% of
violent individuals show a history of self-destructive
behaviour, and up to 20% of suicidal subjects have a
history of violent behaviour (Mann, 1998). Suicide
attempters are more likely to be impulsive and ag-
gressive (Corruble et al. 1999 ; Maiuro et al. 1989;
Pendse et al. 1999 ; Soloﬀ et al. 1994 ; Weissman et al.
1973). It is postulated that increased dopaminergic
activity might lead to greater aggression (Gogos et al.
1998 ; Haller et al. 1998 ; Siegel et al. 1999), and therefore
increased suicidal behaviour.
The enzyme COMT transfers a methyl group to
catecholamines like dopamine, epinephrine and nor-
epinephrine, and it is responsible for their degradation
(Weinshilboum et al. 1999). The enzyme activity is
under control of the COMT gene. A single base-pair
substitution of guanine for adenine results in the
replacement of the amino acid valine (Val) with the
amino acid methionine (Met) at position 158
(Val158Met) in the longer form of the enzyme (mem-
brane-bound COMT or MB-COMT), and at position
108 (Val108Met) in the shorter form (soluble COMT or
S-COMT). This polymorphism (usually referred as
COMT Val108/158Met) aﬀects COMT activity (Lachman
et al. 1996; Lotta et al. 1995). The Val variant of COMT
has a higher stability and activity, and it catabolizes
dopamine up to four times the rate of its Met alter-
native. A functional Val108/158Met polymorphism in
COMT gene inﬂuences aggressive and anger-related
traits in various clinical populations (Kotler et al. 1999 ;
Lachman et al. 1998; Nolan et al. 2000 ; Strous et al.
1997). Since depression and impulsive-aggressive be-
haviour may contribute to suicidal behaviour, it was
suggested that the COMT Val108/158Met polymorphism
might represent a risk factor for suicidal behaviour.
The literature on the relationship between COMT
Val108/158Met and suicidal behaviour is inconsistent,
and both an association between the Met allele and
completed suicide (Ono et al. 2004), suicidal behaviour
(Kia-Keating et al. 2007) or suicide attempts (Baud et al.
2007), or no signiﬁcant association between suicidal
behaviour and COMT Val108/158Met (Russ et al. 2000;
Zalsman et al. 2008) has been reported. The Val/Val
genotype was less frequently detected in male suicide
completers than in male controls (Ono et al. 2004),
while that was not the case in female subjects. These
results suggest that the COMT Val108/158Met poly-
morphism aﬀects the catecholaminergic system dif-
ferently in male and female patients (Ono et al. 2004).
An explanation for this gender-speciﬁc association
could be due to the eﬀects of oestrogen in females
which modulates neurotransmission and neuronal
excitability of the catecholaminergic system
(Balthazart et al. 1996). Since chronic alcohol abuse in-
creases dopaminergic transmission in the brain, while
dopamine mediates the reward processes and alcohol-
induced euphoria (Blum et al. 2007 ; Hosa´k, 2007),
subjects with low-activity allele of the COMTmight be
more vulnerable to develop alcoholism. In line with
this, the Met allele, responsible for the low dopamine
inactivation, has been reported to be associated with
alcoholism (Wang et al. 2001), but inconsistencies
across studies exist (Hosa´k, 2007).The Met allele is
associated with low COMT activity and this may lead
to increased prefrontal dopaminergic activity and
increased aggressive behaviour and consequently
suicidal behaviour, which may result in suicide at-
tempts. Therefore, the hypothesis of this study was
that patients with alcohol dependence who attempted
suicide will be more frequently low-activity COMT
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carriers (Met allele carriers) than alcoholic patients
who did not attempt suicide. Since the association
between COMT Val108/158Met and suicidal behaviour
was detected in male but not in female subjects (Ono
et al. 2004), the additional aim was to elucidate the as-
sociation between COMT Val108/158Met polymorphism
and suicide attempt(s) in ethnically homogenous
medication-free male and female patients with chronic
alcoholism, who frequently develop suicidal behav-
iour and attempt suicide (Sher, 2006).
Method
Participants : patients
Participants were 312 male and 81 female ethnically
homogenous medication-free patients with alcohol
dependence. All subjects were Caucasians of Croatian
origin. Alcohol dependence was diagnosed using the
Structured Clinical Interview for DSM-IV (SCID; First
et al. 2000) according to DSM-IV criteria (APA, 1994).
Civilian patients with alcohol dependence were ad-
mitted into the Psychiatric Hospital Vrapce, due to
withdrawal syndrome.Withdrawal symptoms were of
the non-psychotic type that intensiﬁed 1 wk prior to
admission. Most patients were acutely intoxicated
with alcohol. Therefore, the interview and the sam-
pling were done when the patients were sober, i.e. at
least 12 h after admission to the department. The av-
erage age of male and female subjects was 49.39¡9.75
and 51.79¡11.58 yr, respectively. Based on the SCID
and a psychiatric interview, patients with alcohol de-
pendence were subdivided into patients who at-
tempted suicide (suicidal) and patients who did not
attempt suicide (non-suicidal), and further into suici-
dal and non-suicidal patients with or without diﬀerent
comorbid psychiatric diagnoses. There were 59 male
patients who attempted suicide and 253 male patients
who did not attempt suicide, and 23 female patients
with suicide attempts, and 58 female patients without
a suicide attempt. Within patients, 163 patients had
alcohol dependency without any comorbid diagnoses,
while 230 chronic alcoholics had comorbid psychiatric
diagnoses : 87 patients had depression, anxiety dis-
orders, or anxious depressive disorders, 130 patients
had personality disorders, and 13 patients had devel-
oped other comorbidities such as drug abuse, schizo-
phrenia, acute stress reaction, post-traumatic stress
disorder, mental retardation, dissociative disorders,
organic mental disorders, persistent mood disorders,
phobic anxiety disorders, and adjustment disorders. In
addition to the SCID and a psychiatric interview, ag-
gression and depressive symptoms were assessed
using the Brown–Goodwin Assessment of Life-time
Aggression (Brown–Goodwin Scale ; Brown et al. 1979)
and the Hamilton Rating Scale for Depression
(HAMD) 17-item scale (Hamilton, 1960). The ques-
tionnaire adapted from Brown–Goodwin Scale
(Brown et al. 1979) consisted of seven behavioural
categories (according to Buydens-Branchey et al. 1989),
translated into Croatian: problems with discipline in
the armed forces ; problems with discipline at work;
assaults on other persons ; property damage; incar-
ceration for assaultive behaviour ; incarceration for
other crimes ; crimes that did not result in incarcer-
ation. These categories were evaluated with a 0–4 scale
(0, lack of any problem; 1, one event ; 2, two or a few
events ; 3, three or several or frequent events ; 4, four
events or more, or many or numerous events). The
total maximum score was 28, and according to
Buydens-Branchey et al. (1989), a cut-oﬀ score of 8 was
designated as aggressive behaviour.
Participants : control subjects
The control group consisted of 487 male and 122
female unrelated, medication-free Caucasian healthy
subjects of Croatian origin, who were recruited during
the period between 2005 and 2009 at the University
Hospital Centre Zagreb, Croatia, and who completed
the questionnaire answering questions about their
medical history, smoking and drinking habits. All
individuals gave their detailed medical history. In-
clusion criteria were no current medication therapy;
no previous or current psychiatric disorders ; no drug
or alcohol abuse, no suicide attempts ; no family his-
tory of psychiatric disorders (determined according to
the answers of participants about the mental health
status of their parents, grandparents, siblings and
children) ; not being related; and belonging to the
native ethnic group with at least three generations
living in the region.
Written informed consent was obtained from all
participants, after explaining the aims and procedures
of the study, under guidelines approved by the Ethics
Committees of the Psychiatric Hospital Vrapce, and
University Hospital Centre Zagreb, Croatia. All hu-
man studies have been executed with the full cooper-
ation of participants, adequate understanding, and
have therefore been performed in accordance with the
ethical standards laid down in the 1964 Declaration of
Helsinki.
Blood collection
The sampling of patients with alcoholism was done
when the patients were sober, i.e. at least 12 h after
admission to the department, at 08 :00 hours. Blood
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samples (8 ml) from patients and control subjects were
drawn in a plastic syringe with 2 ml acid citrate dex-
trose anticoagulant.
Genotyping
Genomic DNA was extracted from peripheral blood
using a salting-out method (Miller et al. 1988). The
COMT Val108/158Met polymorphism was genotyped
in an ABI Prism 7000 Sequencing Detection System
apparatus (ABI) using a TaqMan-based allele-speciﬁc
polymerase chain reaction assay, according to the
manufacturer’s instructions (Applied Biosystems,
USA). The primers and probes were purchased from
Applied Biosystems as TaqMan1 Drug Metabolism
Genotyping Assay (assay ID: C_25746809_50; order
no. : 43262691).
Statistical evaluation
The results were expressed as means¡standard
deviations (S.D.) or numbers and percentages, and
evaluated with Sigma Stat 3.5 (Jandell Scientiﬁc Corp.,
USA) and Microsoft Excel. The diﬀerences in age
were assessed using one-way analysis of variance
(ANOVA). The diﬀerences in the Brown–Goodwin or
HAMD scores were evaluated with Kruskal–Wallis
ANOVA on ranks, followed by a non-parametric
Mann–Whitney rank sum test, since the normality test
failed. Hardy–Weinberg analysis was used to test the
equilibrium of the population. The diﬀerences in the
genotype and allele frequencies were evaluated using
a x2 test, with Yates correction for continuity, and
with standardized residuals (R), to determine what
category was a major contributor to rejecting the null
hypothesis. The power of calculation (power), which
should be 0.800, was evaluated using Sigma Stat 3.5.
A Bonferroni correction was used for multiple testing,
and the level of signiﬁcance was set to a=0.025.
Results
To elucidate the possible diﬀerence in the frequency
of the COMT variants between 312 male and 81 female
medication-free Caucasian patients with alcohol de-
pendence (alcoholics), and 487 male and 122 female
healthy control non-alcoholic and non-suicidal sub-
jects, the Met/Met, Met/Val and Val/Val genotypes
and Met and Val alleles were compared between
healthy and alcoholic subjects. The genotype (x2=
3.456, d.f.=6, p=0.738, power=0.234) and allele
(x2=1.881, d.f.=3, p=0.587, power=0.176) frequency
of the COMT Val108/158Met did not diﬀer signiﬁcantly
between male and female alcoholic subjects and male
and female healthy subjects. These results were con-
ﬁrmed when healthy and alcoholic subjects were not
subdivided according to gender, since there was no
signiﬁcant diﬀerence in the distribution of the geno-
types (x2=1.546, d.f.=6, p=0.462, power=0.174) and
alleles (x2=0.997, d.f.=1, p=0.318, power=0.157) be-
tween groups. The genotype distribution in male (x2=
1.880, d.f.=1, p=0.170) or female (x2=0.063, d.f.=1,
p=0.802) alcoholics, or in male (x2=0.356, d.f.=1,
p=0.551) or female (x2=0.295, d.f.=1, p=0.587) con-
trol subjects was in the expected Hardy–Weinberg
equilibrium.
Within alcoholic patients, no signiﬁcant (x2=2.953,
d.f.=1, p=0.086, power=0.388) diﬀerence was found
in the frequency of suicide attempts between male and
female alcoholics. Furthermore, the participant groups
were matched for age, and there were no signiﬁcant
diﬀerences in age of the alcoholics subdivided into
male and female alcoholics with or without suicide
attempts (Table 1). Since the power of calculation was
below the desired power of 0.800, these results should
be repeated on larger samples.
There were no signiﬁcant diﬀerences from the ex-
pected Hardy–Weinberg equilibrium in the genotype
distribution in male alcoholics with suicide attempts
(x2=0.068, d.f.=1, p=0.794) or male alcoholics with-
out suicide attempts (x2=3.471, d.f.=1, p=0.062), or
in female alcoholics with suicide attempts (x2=0.016,
d.f.=1, p=0.899) or female alcoholics without suicide
attempts (x2=0.172, d.f.=1, p=0.678).
Table 1 shows the signiﬁcant diﬀerences (after
Bonferroni correction) in the frequencies of Met/Met,
Met/Val and Val/Val genotypes, Met and Val alleles,
and Val carriers vs. homozygous Met/Met genotype,
between male alcoholics with or without suicide at-
tempts. These diﬀerences were due to the signiﬁcantly
higher frequency of Met/Met genotype (44.1%) in
male alcoholics who attempted suicide compared to
male alcoholics who did not attempt suicide (19.8%).
The absolute values of the standardized residuals for
the Met/Met genotype compared to other COMT
genotypes, and for the homozygous Met/Met geno-
type compared to Val carriers were R=3.07 and R=
3.20, respectively, conﬁrming their major contribution
to the signiﬁcant eﬀect in the x2 statistics. These data
had enough statistical power (p>0.800) to detect sig-
niﬁcant eﬀect. Within female alcoholics with or with-
out suicide attempts, no signiﬁcant diﬀerence in the
frequency of COMT variants was found, but the lack
of signiﬁcant diﬀerences might be due to the lack of
power (Table 1).
To evaluate the possible inﬂuence of gender on the
COMT variants and suicide attempt (Ono et al. 2004),
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Met/Met, Met/Val and Val/Val genotypes and Met
and Val alleles were compared in male and female
alcoholics with and without suicide attempts. No sig-
niﬁcant gender-related diﬀerences were found in the
frequencies of the genotypes (x2=0.234, d.f.=2, p=
0.889) or alleles (x2=0.084, d.f.=1, p=0.771) in
alcoholic men and women with suicide attempts, or in
the genotypes (x2=0.185, d.f.=2, p=0.912) or alleles
(x2=0.006, d.f.=1, p=0.916) in male and female alco-
holics who did not attempt suicide. However, power
of calculation (0.056–0.066) was below the desired
power of 0.800, indicating that we might have failed to
detect gender-related diﬀerences in COMT variants
between male and female alcoholics with and without
suicide attempts. When the data frommale and female
alcoholics were collapsed, signiﬁcant diﬀerences were
detected in the frequencies of the genotypes (x2=
18.484, d.f.=2, p=0.001, power=0.987) or alleles
(x2=16.020, d.f.=1, p=0.001, power=0.989) between
alcoholics with or without suicide attempts. These
data conﬁrmed the results obtained in male alcoholics,
and showed with a high statistical power that the
higher frequency of the Met/Met genotype (R=3.13)
in suicidal alcoholics contributed to the signiﬁcance of
the x2 statistics.
Since COMT Val108/158Met variants might be asso-
ciated with smoking, as was shown for healthy sub-
jects (Nedic et al. 2010), we additionally evaluated the
eﬀect of smoking in male or female alcoholics with or
without suicide attempts. The frequency of genotypes
did not diﬀer signiﬁcantly between male alcoholic
smokers and non-smokers with (x2=0.798, d.f.=2,
p=0.671, power=0.110) or without (x2=0.672, d.f.=2,
p=0.714, power=0.100) suicide attempts, or between
female alcoholic smokers and non-smokers with (x2=
1.312, d.f.=2, p=0.519, power=0.154) or without (x2=
2.340, d.f.=2, p=0.310, power=0.246) suicide at-
tempts.
As suicide attempts in alcoholism are usually asso-
ciated with increased aggression, and/or comorbid
depression (Buydens-Branchey et al. 1989; Sher, 2006),
in the subsequent analyses we evaluated genotype-
related diﬀerences in the mean total scores in the
modiﬁed Brown–Goodwin Scale and HAMD scores
between alcoholics with or without suicide attempts.
In male, but not in female alcoholics with or without
Table 1. COMT Val108/158Met variants in male and female alcoholics with suicide attempt (suicidal) or without suicide
attempt (non-suicidal)
Alcoholics (N=393)
Men (n=312) Women (n=81)
Suicidal (n=59) Non-suicidal (n=253) Suicidal (n=23) Non-suicidal (n=58)
No. (%) No. (%) No. (%) No. (%)
Genotypes
Met/Met 26 (44.1) 50 (19.8) 9 (39.1) 15 (25.9)
Met/Val 27 (45.7) 141 (55.7) 11 (47.8) 29 (50.0)
Val/Val 6 (10.2) 62 (24.5) 3 (13.1) 14 (24.1)
x2 test x2=16.997, d.f.=2, p<0.001, power=0.977 x2=1.960, d.f.=2, p=0.375, power=0.211, n.s.
Alleles
Met 79 (67.0) 241 (47.6) 29 (63.0) 59 (50.9)
Val 39 (33.0) 265 (52.4) 17 (37.0) 57 (49.1)
x2 test, Yates correction x2=13.534, d.f.=1, p<0.001, power=0.972 x2=1.509, d.f.=1, p=0.219, power=0.217, n.s.
Val carriers
Val/Val+Met/Val 33 (55.9) 203 (80.2) 14 (60.9) 43 (74.1)
Met/Met 26 (44.1) 50 (19.8) 9 (39.1) 15 (25.7)
x2 test, Yates correction x2=14.048, d.f.=1, p<0.001, power=0.977 x2=0.827, d.f.=1, p=0.363, power=0.138, n.s.
Mean¡S.D. Mean¡S.D. Mean¡S.D. Mean¡S.D.
Age (yr) 50.58¡9.17 49.12¡9.88 50.35¡10.01 52.36¡12.18
ANOVA F=1.738, d.f.=3, 389, p=0.159, power=0.201, n.s.
n.s., Not signiﬁcant.
Frequencies (in %) are shown in parentheses.
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suicide attempts, Kruskal–Wallis ANOVA on ranks
revealed signiﬁcant genotype-related diﬀerences in
the Brown–Goodwin (Table 2) and HAMD (Table 3)
scores.
Signiﬁcantly higher (Mann–Whitney test) ag-
gression scores (evaluated using the modiﬁed
Brown–Goodwin Scale) were detected in male alco-
holics with suicide attempts, who were carriers of
Met/Met (p=0.019) or Met/Val (p=0.017) genotypes
than in the corresponding male alcoholics without
suicide attempts who were carriers of Met/Met or
Met/Val genotypes. The aggression scores did not
diﬀer signiﬁcantly between female alcoholics sub-
divided according to the COMT variants, with or
without suicide attempts. Although male alcoholics
had higher aggression scores than female alcoholics,
signiﬁcant gender-related diﬀerences were found only
between male alcoholic patients with the Met/Val
genotype with (p=0.013) or without (p=0.001) suicide
attempts compared to the scores in the corresponding
female alcoholic patients with the Met/Val genotype
with or without suicide attempts (Table 2).
The total scores in the HAMD, showing the severity
of depressive symptoms, were signiﬁcantly (Mann–
Whitney test) higher in male alcoholics with suicide
attempts, who were carriers of Met/Met (p=0.008)
or Met/Val (p=0.005) genotypes than in the corre-
sponding male alcoholics without suicide attempts
who were carriers of Met/Met or Met/Val genotypes.
There was no signiﬁcant diﬀerence in the HAMD
scores between female alcoholics with diﬀerent COMT
variants with or without suicide attempts. Female al-
coholics who attempted suicide with the Val/Val
genotype had signiﬁcantly (p=0.024) higher HAMD
scores than male alcoholics who attempted suicide
with the Val/Val genotype (Table 3).
Table 2. Comparisons of the total aggression scores, evaluated using the modiﬁed Brown–Goodwin Scale, among the COMT
Val108/158Met genotype groups in male and female alcoholics
Total scores on the modiﬁed Brown–Goodwin Scale (COMT Val108/158Met)
AA (Met/Met) AG (Met/Val) GG (Val/Val) Kruskal–Wallis ANOVA on ranks
Male alcoholics
With suicide attempt 7.58¡5.55 7.07¡4.16 8.33¡4.72 H=15.060, d.f.=5, p=0.010, power=0.738
Without suicide attempt 4.50¡3.94* 4.96¡4.48** 5.76¡4.30
Female alcoholics
With suicide attempt 3.44¡1.94 2.82¡3.28 7.00¡3.61 H=7.909, d.f.=5, p=0.161, power=0.161, n.s.
Without suicide attempt 2.07¡2.02 2.34¡3.20 3.57¡ 4.85
n.s., Not signiﬁcant.
* p=0.019 vs. the scores in male alcoholics with Met/Met genotype with suicide attempt ; **p=0.017 vs. the scores in male
alcoholics with Met/Val genotype with suicide attempt (Mann–Whitney test).
Table 3. Comparisons of the total HAMD scores among the COMT Val108/158Met genotype groups in male and female alcoholics
Total HAMD scores (COMT Val108/158Met)
AA (Met/Met) AG (Met/Val) GG (Val/Val) Kruskal–Wallis ANOVA on ranks
Male alcoholics
With suicide attempt 23.23¡8.32 23.89¡6.64 19.33¡4.88 H=17.659, d.f.=5, p=0.003, power=0.840
Without suicide attempt 17.94¡6.52* 19.58¡7.13** 21.29¡7.70
Female alcoholics
With suicide attempt 22.78¡5.40 24.91¡5.12 28.33¡2.52 H=6.144, d.f.=5, p=0.292, power=0.050, n.s.
Without suicide attempt 22.87¡12.66 21.31¡7.50 21.57¡8.86
HAMD, Hamilton Rating Scale for Depression; n.s., not signiﬁcant.
* p=0.008 vs. the scores in male alcoholics with Met/Met genotype with suicide attempt ; ** p=0.005 vs. the scores in male
alcoholics with Met/Val genotype with suicide attempt (Mann–Whitney test).
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In order to explore the possible inﬂuence of co-
morbid diagnoses on COMT variants in alcoholic
patients with and without suicide attempts, male and
female suicide attempters and non-attempters were
subdivided into groups without and with comorbid
psychiatric diagnoses (mostly depression, anxiety and
personality disorders). As shown in Table 4, signiﬁ-
cant diﬀerences were found in the frequencies of Met/
Met, Met/Val and Val/Val genotypes, and Met and
Val alleles between male, but not female, suicidal and
non-suicidal alcoholics, with comorbid psychiatric
diagnoses. This signiﬁcance was induced by a higher
frequency of the Met/Met genotype (47.1%) in male
suicidal alcoholics compared to male non-suicidal al-
coholics (16.9%), showing a signiﬁcant contribution
of the Met/Met genotype (R=3.01). The frequencies
of Met/Met, Met/Val and Val/Val genotypes, and
Met and Val alleles did not diﬀer signiﬁcantly within
suicidal and non-suicidal male or female alcoholics
without comorbid psychiatric diagnoses (Table 4).
Due to the smaller numbers, these data lacked the
statistical power (p<0.800).
Table 4. COMT Val108/158Met variants in male and female suicidal and non-suicidal alcoholics, subdivided further into
alcoholics without and with comorbid diagnoses
Alcoholics without comorbid diagnoses (N=163)
Men (n=137) Women (n=26)
Suicidal (n=8) Non-suicidal (n=129) Suicidal (n=5) Non-suicidal (n=21)
No. (%) No. (%) No. (%) No. (%)
Genotypes
Met/Met 2 (25.0) 29 (22.5) 3 (60.0) 7 (33.3)
Met/Val 5 (62.5) 73 (56.6) 2 (40.0) 9 (42.9)
Val/Val 1 (12.5) 27 (20.9) 0 (0.0) 5 (23.8)
x2 test x2=0.329, d.f.=2, p=0.484, power=0.073, n.s. x2=1.945, d.f.=2, p=0.378, power=0.210, n.s.
Alleles
Met 9 (56.3) 131 (50.8) 8 (80.0) 23 (54.8)
Val 7 (43.7) 127 (49.2) 2 (20.0) 19 (45.2)
x2 test, Yates
correction
x2=0.028, d.f.=1, p=0.867, power=0.050, n.s. x2=1.217, d.f.=1, p=0.270, power=0.183, n.s.
Alcoholics with comorbid diagnoses (N=230)
Men (n=175) Women (n=55)
Suicidal (n=5) Non-suicidal (n=124) Suicidal (n=18) Non-suicidal (n=37)
No. (%) No. (%) No. (%) No. (%)
Genotypes
Met/Met 24 (47.1) 21 (16.9) 6 (33.3) 8 (21.6)
Met/Val 22 (43.1) 68 (54.9) 9 (50.0) 20 (54.1)
Val/Val 5 (9.8) 35 (28.2) 3 (16.7) 9 (24.3)
x2 test x2=19.080, d.f.=2, p=0.001, power=0.988 x2=1.016, d.f.=2, p=0.602, power=0.050, n.s.
Alleles
Met 70 (68.6) 100 (42.0) 21 (58.3) 36 (48.7)
Val 32 (31.4) 138 (58.0) 15 (41.7) 38 (51.3)
x2 test, Yates
correction
x2=19.174, d.f.=1, p=0.001, power=0.997 x2=0.563, d.f.=1, p=0.453, power=0.108, n.s.
n.s., Not signiﬁcant.
Frequencies (in %) are shown in parentheses.
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Discussion
This study provides the ﬁrst evidence of the signiﬁcant
association between the COMT Val108/158Met poly-
morphism and suicide attempts in ethnically homo-
genous Caucasian groups of medication-free patients
with alcohol dependence. Our results showed signiﬁ-
cant diﬀerences in the frequencies of COMT variants
(i.e. Met/Met, Met/Val and Val/Val genotypes, Met
or Val alleles, or Val carriers vs. homozygous Met/Met
genotype) among male, but not female alcoholics with
or without suicide attempts. Namely, alcoholic men
who attempted suicide had the higher frequency of the
Met/Met genotype or the Met allele than alcoholic
men who did not attempt suicide. When the data from
male and female alcoholic patients were collapsed,
suicide attempts were signiﬁcantly associated with the
Met/Met genotype and the Met allele, conﬁrming an
involvement of the Met/Met genotype in the devel-
opment of suicidal behaviour in alcoholic patients. In
agreement with our results, the Val/Val genotype was
less frequently detected in male suicide completers
than in male controls (Ono et al. 2004), suggesting that
Val/Val could be a factor that protects against suicide,
especially in male patients, and that the Met allele,
independently of diagnosis, may be a risk factor for
violent suicide. Our data are in line with a meta-
analysis showing a signiﬁcant association between the
COMT Val108/158Met polymorphism and suicidal be-
haviour (Kia-Keating et al. 2007), and with evidence
for an association of the COMT polymorphism and
suicide attempts in schizophrenia and schizoaﬀective
patients (Kotler et al. 1999 ; Lachman et al. 1998;
Nolan et al. 2000 ; Strous et al. 1997). An association
between the Met/Met genotype and violent suicide
attempts was also found in other studies (Nolan et al.
2000 ; Rujescu et al. 2003), which indicates that the
Val108/158Met polymorphism may modify the clinical
phenotype of suicidal behaviour. The Met allele is as-
sociated with low COMT activity and this may lead
to increased prefrontal dopaminergic activity and in-
creased aggressive behaviour. Our results have con-
ﬁrmed the hypothesis that the low COMT activity
variant is associated with suicide attempts. This sig-
niﬁcant association was not inﬂuenced by smoking,
which is related to higher frequency of the Val/Val
genotypes in smokers (Nedic et al. 2010 ; Tochigi et al.
2007), as our data showed that tobacco smoking did
not signiﬁcantly aﬀect the frequency of COMT var-
iants in male or female alcoholic smokers and non-
smokerswith orwithout suicide attempts. In our study,
the control group was used to compare the frequencies
in COMT variants between chronic alcoholics and
control subjects in an ethnically homogenous group of
Caucasians of Croatian origin. Although we expected
that the Met/Met genotype would be associated with
alcoholism due to the lower COMT activity and more
dopamine release in the brain, and the consequently
elevated rewarding eﬀects of alcohol consumption
(Blum et al. 2007), our results showed a similar distri-
bution of the COMT variants between male and
female alcoholics and healthy control male and fe-
male subjects, or between all alcoholics and all control
subjects. This ﬁnding disagrees with previously pub-
lished data (Tiihonen et al. 1999), presumably due to
diﬀerences in sample sizes and diﬀerences in the in-
clusion of only late-onset alcoholics vs. both early and
late-onset alcoholics in the present study. There-
fore, COMT Val108/158Met was associated with suicide
attempts in alcoholism, but not with alcoholism as a
diagnostic entity, or with smoking.
In contrast to our data, some reports have found no
diﬀerences in the genotype frequencies of functional
polymorphisms in the COMT gene between suicidal
in-patients and control subjects (De Luca et al. 2005;
Liou et al. 2001 ; Russ et al. 2000 ; Zalsman et al. 2008),
and one study even found that the Val/Val genotype
was more frequently detected in suicide attempters
than in normal controls (Baud et al. 2007). These dif-
ferences between studies might be explained by the
diﬀerent diagnostic entities used across the studies,
since we evaluated patients with alcohol dependence,
while other studies included patients with schizo-
phrenia, schizoaﬀective or mood disorders. Further-
more, we compared alcoholics who attempted and
who never attempted suicide, while other studies
evaluated patients with suicidal behaviour (which
includes suicide ideation, thoughts and plans in ad-
dition to attempts).
Similarly to the lack of signiﬁcant diﬀerences re-
ported between female suicide completers and con-
trols in either genotype or allele frequencies (Ono et al.
2004), we did not detect signiﬁcant diﬀerences in the
COMT variants between female alcoholics with or
without suicide attempts. This lack of signiﬁcant
association was due to the smaller number of female
alcoholics in the present study, and a lack of statistical
power, since female alcoholic patients who attempted
suicide also had a marginally higher frequency of the
Met/Met genotype (39.1%) than female alcoholics
who did not attempt suicide (25.9%), and in addition,
suicidal alcoholic women had a slightly lower fre-
quency of the Val/Val genotype (13.1%) than female
alcoholics without suicide attempts (24.1%). Namely,
the data found in female alcoholics with or without
suicide attempts were similar to genotype and allele
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frequencies detected in the larger groups of corre-
sponding male alcoholics, and when the data from
both genders were collapsed, and had enough stat-
istical power, all alcoholics with suicide attempts had
signiﬁcantly higher frequency of the Met/Met geno-
types than those without suicide attempts.
In contrast to data showing that a higher proportion
of females attempt suicide in the USA (Kia-Keating
et al. 2007), although men are more successful in com-
mitting suicide, in our study there was a similar fre-
quency of suicide attempts between male and female
alcoholics of Croatian origin.
Gender-related diﬀerences were not detected in
the frequency of COMT variants between alcoholic
patients with or without suicide attempts, due to the
much smaller number of female alcoholics, conse-
quent lack of power of calculation, and the type I error,
which represents a limitation of the study. On the
other hand, clear gender-related diﬀerences were
found in the scores measuring aggression and de-
pression. All aggression scores were higher in male
than in female alcoholic patients, while male alco-
holics with the Met/Val genotype, with or without
suicide attempts, had signiﬁcantly higher aggression
scores than the corresponding female alcoholics.
Within male alcoholics, those with suicide attempts,
or carriers of Met/Met or Met/Val genotypes, had
signiﬁcantly higher Brown–Goodwin Scale scores and
HAMD scores, than those without suicide attempts
who were carriers of the corresponding genotypes.
The ﬁnding of the higher aggression scores in our al-
coholic suicidal Met carriers agrees with the signiﬁ-
cant association detected between the Met allele and
a history of violent suicide attempts in male, but not
in female schizophrenic and schizoaﬀective patients
(Nolan et al. 2000), or between the Met/Met genotype
and aggression in male homicidal schizophrenia
patients (Kotler et al. 1999), or between the Met allele
and violent suicide attempts in patients with various
psychiatric diagnoses (Rujescu et al. 2003), suggesting
a major role of catecholaminergic pathways in the
mediation of self- and other-directed aggression
(Nolan et al. 2000). Our results are not in line with the
lack of signiﬁcant association between COMT variants
and violence or suicide attempts in schizophrenia pa-
tients (Liou et al. 2001), or between COMT variants and
a history of suicide attempts, and lethality or method
of suicide attempt, or with aggressive/impulsive traits
in the large group of mood disorder subjects (Zalsman
et al. 2008).
The low COMT activity variant might present a risk
factor for violent suicide, independent of diagnosis
(Rujescu et al. 2003), since the Met/Met genotype was
associated with higher scores on anger-related traits
(Rujescu et al. 2003). This is in line with the higher
frequency of the Met/Met genotype in suicidal com-
pared to non-suicidal male alcoholics with diﬀerent
comorbid psychiatric diagnoses. Although alcoholic
patients without comorbid diagnoses had similar
frequency of the COMT variants, this result might be
due to a lack of the statistical power, and the fact that
chronic alcoholic patients frequently develop other
comorbid diagnoses (Ducci et al. 2007 ; Sher, 2006).
In agreement with the proposed risk factors for at-
tempted and completed suicide in alcoholism, such as
high aggression and impulsivity, alcoholism severity,
major depressive episode, stressful life events, social
problems and hopelessness (Sher, 2006), our results
suggest that Met carriers with chronic alcoholism and
comorbid depression, anxiety and personality dis-
orders are at risk of attempting suicide. Our data
might be explained by the fact that carriers of the low
COMT activity variants are more prone to develop
aggression due to poor dopamine metabolism, and
therefore have increased concentrations of prefrontal
dopamine which may be associated with aggressive
behaviour and increased expression of anger-related
traits (Rujescu et al. 2003), and suicide behaviour.
Within female alcoholic patients, there were no
signiﬁcant diﬀerences in the aggression and de-
pression scores between carriers of COMT variants
with or without suicide attempts. These results dis-
agree with the gender-mediated eﬀect on two State-
Trait Anger Expression Inventory subscales – Trait
Anger and Anger Control, since it has been reported
that the Val/Val genotype markedly aﬀects the scores
in female suicide attempters (Baud et al. 2007), while in
our study this association was marginal but not sig-
niﬁcant. The HAMD scores were signiﬁcantly higher
in female suicidal alcoholics with the Val/Val geno-
type compared to the corresponding male suicidal
alcoholics, showing that alcoholic women frequently
develop depressive symptoms. These results indicate
that the COMT genotype might have a possible
gender-related eﬀect on a personality trait (Baud et al.
2007).
In conclusion, we have found that Met carriers were
over-represented in male alcoholic suicide attempters,
in all alcoholics, and in alcoholics with comorbid
psychiatric diagnoses. In addition, male alcoholic
suicide attempters who were Met carriers showed
higher levels of aggression and depression than the
corresponding non-attempters, conﬁrming the asso-
ciations previously found between the Met allele with
aggressive behaviours or violent suicide attempts in
schizophrenia (Kotler et al. 1999 ; Lachman et al. 1998 ;
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Nolan et al. 2000 ; Strous et al. 1997) or depressive dis-
orders (Ohara et al. 1998). Our results conﬁrmed that
the Met allele of the COMT Val108/158Met polymorph-
ism might be used as an independent biomarker of
suicidal behaviour across diﬀerent psychopathologies.
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